Related Experiment Videos
Fixed drug eruptions: evidence for a cytokine-mediated process
B R Smoller1, A D Luster, J F Krane
1Department of Dermatopathology, New York Hospital, New York.
Journal of Cutaneous Pathology
|February 1, 1991
Summary
Fixed drug eruptions (FDE) involve immune responses causing recurring skin lesions. This study suggests cytokines, like gamma-interferon, play a role in FDE pathogenesis.
Area of Science:
- Immunodermatology
- Cutaneous immunology
- Pathogenesis of drug reactions
Background:
- Fixed drug eruptions (FDE) are characterized by recurrent skin lesions upon re-exposure to specific drugs.
- The precise immunological mechanisms underlying FDE remain incompletely understood.
- T-lymphocyte infiltration is a known feature of FDE lesions.
Purpose of the Study:
- To investigate the potential role of cytokines, specifically gamma-interferon, in the pathogenesis of fixed drug eruptions.
- To examine the expression of HLA-DR and gamma-interferon-induced protein 10 (IP-10) in FDE biopsies.
Main Methods:
- Biopsies from 6 patients with clinically diagnosed FDE were analyzed.
- Immunohistochemistry was performed using antibodies against HLA-DR and IP-10.
- Staining patterns in lymphocytes, keratinocytes, and endothelial cells were evaluated.
Main Results:
- All FDE biopsies showed staining of dermal lymphocytes with anti-HLA-DR antibody.
- Keratinocytes exhibited IP-10 antibody staining throughout the epidermis, particularly in blistered areas.
- Increased IP-10 staining in keratinocytes correlated with higher dermal infiltration of HLA-DR positive lymphocytes.
Conclusions:
- Findings support the hypothesis that fixed drug eruptions are cell-mediated immune responses.
- Cytokine-mediated processes, involving gamma-interferon signaling, likely contribute to the observed histological changes in FDE.
- This research sheds light on the immunologic underpinnings of fixed drug eruptions.